E-ISSN 2636-834X
 

Original Research 


The review of hematologic and other biochemical parameters in lithium monotherapy patients

tevfik kalelioğlu, akif taşdemir, abdullah genç, esra sena genç, ismail özver, dilek yeşilbaş, kürşat altınbaş, erhan kurt.

Cited By: 2

Abstract
Aims: Long term treatment with lithium has been suggested to cause prominent toxic effects on different organs and systems. We aimed to investigate the effect of lithium on liver, kidney, and thyroid functions and hematopoietic system in euthymic patients with bipolar mood disorder, who have been on lithium monotherapy.
Methods: The medical charts of the bipolar patients from January 2009 to January 2011 were screened. Liver, kidney, and thyroid function test results and complete blood count parameters were recorded. The data of patients, who were under lithium monotherapy for three months or longer, were included in the study.
Results: A total of sixty five patients were included in this study and 41.5% of the patients (n=27) were male and 58.5% (n=38) were female. All patients were diagnosed with Type I Bipolar Disorder. The mean age of the patients was 40.47±11.41; 41.84±12.49 years for females versus 38.88±9.61 years for males (p=0.313). The mean duration of illness was 16.70±9.86 years and the received mean lithium dose was 1160±274 mg/day. The duration of lithium therapy was 156.29±117.53 weeks (min: 12 max: 410); 139.26±130.20 weeks in males and 168.39±107.80 weeks in females (p=0.207). There were significant differences between genders for creatinine, uric acid, and creatinine levels (p<0.001, p<0.001, and p=0.034, respectively) and for hemoglobin, hematocrit, and MPV values (p<0.001, p<0.001, p=0.019, respectively). Hematocrit values of the 13,8% of women were below the reference range, however hematocrit values of male patients were between reference range (χ2=7.422, p=0.006). There were higher neutrophil levels in 47.7% of patients, thrombocytopenia in the 4.6% of patients, and thrombocytosis in the 4.6% of patients. There were no significant differences between gender according to average values of fT3 (p=0.173), fT4 (p=0.167), and TSH (p=0.170).
Conclusion: Kidney and liver functions in patients with bipolar mood disorder, who have been on long term lithium monotherapy generally seemed to be in reference range, however some differences were observed in some patients. The side effects of lithium monotherapy on the different organs or systems were similar to reported findings in the literature.

Key words: lithium monotherapy, metabolic parameters, thyroid, hematological system


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by tevfik kalelioğlu
Articles by akif taşdemir
Articles by abdullah genç
Articles by esra sena genç
Articles by ismail özver
Articles by dilek yeşilbaş
Articles by kürşat altınbaş
Articles by erhan kurt
on Google
on Google Scholar


REFERENCES
Smith LA, Cornelius V, Warnock A, Bell A, Young AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord, 2007;9, 394-412.
Ahmad M, Elnakady Y, Farooq M, W Adaan M. Lithium Induced Toxicity in Rats: Blood Serum Chemistry, Antioxidative Enzymes in Red Blood Cells and Histopathological Studies. Biol. Pharm. Bull. 2011;34(2) 272-77.
Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am. J. Kidney Dis. 1987;10, 329-45.
McCann SM, Daly J, Kelly CB. The Impact Of Long-Term Lithium Treatment On Renal Function In An Outpatient Population. Ulster Med J 2008;77 (2) 102-5.
Bendz H, Schon S, Attman PO, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int. 2010;77, 219-24.
Oyesanmi O, Kunkel EJS, Monti DA., Field HL. Hematologic Side Effects of Psychotropics. Psychosomatics 1999;40:414-21. [DOI via Crossref]   
Anon: Drug treatments for bipolar disorder: maintenance, prevention and special situations. Drug and Therapeutics Bulletin 2005;43:33-7.
Glover KJ, Lawley D: How safe is lithium prescribing? Audit of a local prescribing framework and patient survey. Psychiatr Bull 2005,29:98-100.
Eþel E, Sofuoglu S, Gonul AS, Turan MT, Baþturk M, Tutuþ A, Kose K. Bipolar Hastalarda Kisa ve Uzun Sureli Lityum Tedavisinin Tiroid Hormonlari Üzerine Etkisi. Turk Psikiyatri Dergisi 2001;12(3):195-201
De Oliveira JL, Da Silva GB, De Abreu AKLS, De Albuquerque RN, Franco LFLG, AraúJo SMH, et al. Lithium nephrotoxicity. Rev Assoc Med Bras. 2010;56(5): 600-6.
Tredget J, Kirov A, Kirov G. Effects of chronic lithium treatment on renal function. J Aff Disorders. 2010;126:436-40 [DOI via Crossref]    [Pubmed]   
Bassilios N, Martel P, Godard V, Froissart M, Grunfeld JP, Stengel B, et al. Monitoring of glomerular &#64257;ltration rate in lithium-treated outpatients an ambulatory laboratory database surveillance. Nephrol. Dial. Transplant. 2008;23, 562-65.
Bendz H, Aurell M, Balldin J, Mathé AA, Sjodin I. Kidney damage in long-term lithium patients: a cross-sectional study of patients with 15 years or more on lithium. Nephrol. Dial. Transplant. 1994;9, 1250-54.
Bendz H, Aurell M, Lanke J. A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. Eur. Psychiatry. 2001;16, 199-206.
McCann, SM, Daly J, Kelly CB. The impact of long-term lithium treatment on renal function in an outpatient population. Ulster Med. J. 2008;77, 102-5.
Janowsky, DS, Soares, J, Hatchm JP, Zunta-Soares G, Hu Q, Davis JM. Lithium effect on renal glomerular function in individuals with intellectual disability. J. Clin. Psychopharmacol. 2009;29, 296-9.
Chadha VD, Bhalla P, Dhawan D. Uptake and retention of 65Zn in lithium-treated rat liver: role of zinc. Dig Liver Dis. 2010;42(6):446-50. [DOI via Crossref]    [Pubmed]   
Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23(6):723-33. [DOI via Crossref]    [Pubmed]   
Focosi D, Azzarà A, Kast RE, Carulli G, Petrini M. Lithium and hematology: established and proposed uses. J Leukoc Biol 2009;85(1):20-8. [DOI via Crossref]    [Pubmed]   
Turan MT, Esel E, Tutus A, Sofuoglu S, Gonuk AS. Lithium-induced alterations in parathormone function in patients with bipolar disorder. Bull Clin Psychopharmacol 2001;11:96-100
Sofuoglu S, Basturk M, Tutus A, Karaaslan F, Aslan SS, Gonuk AS. Lithium- induced alterations in parathormone function in patients with bipolar affective disorder. Int J Neuropsychopharmacol 1999;2:S56
Cohen O, Rais T, Lepkifker E, Vered I. Lithium carbonate therapy is not a risk factor for osteoporosis. Horm Metab Res. 1998 Sep;30(9):594-7.

This Article Cited By the following articles

Idiopathic Thrombocytopenia Side-Effect of Lithium in a Patient with Schizophrenia
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2013; 23(2): 180.

1
 
Extended-release carbamazepine versus lithium in management of acute mania in male inpatients with bipolar I disorder
Psychiatry and Clinical Psychopharmacology 2018; (): 1.

2
 
How to Cite this Article
Pubmed Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. PBS. 2012; 2(3): 109-114. Turkish. doi:10.5455/jmood.20120711044126


Web Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. https://www.pbsciences.org/?mno=16879 [Access: March 28, 2023]. Turkish. doi:10.5455/jmood.20120711044126


AMA (American Medical Association) Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. PBS. 2012; 2(3): 109-114. Turkish. doi:10.5455/jmood.20120711044126



Vancouver/ICMJE Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. PBS. (2012), [cited March 28, 2023]; 2(3): 109-114. Turkish. doi:10.5455/jmood.20120711044126



Harvard Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt (2012) [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. PBS, 2 (3), 109-114. Turkish. doi:10.5455/jmood.20120711044126



Turabian Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. 2012. [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. Psychiatry and Behavioral Sciences, 2 (3), 109-114. Turkish. doi:10.5455/jmood.20120711044126



Chicago Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. "[The review of hematologic and other biochemical parameters in lithium monotherapy patients]." Psychiatry and Behavioral Sciences 2 (2012), 109-114. Turkish. doi:10.5455/jmood.20120711044126



MLA (The Modern Language Association) Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt. "[The review of hematologic and other biochemical parameters in lithium monotherapy patients]." Psychiatry and Behavioral Sciences 2.3 (2012), 109-114. Print.Turkish. doi:10.5455/jmood.20120711044126



APA (American Psychological Association) Style

tevfik kalelioğlu, akif taşdemir, abdullah genc, esra sena genc, ismail ozver, dilek yeşilbaş, kurşat altınbaş, erhan kurt (2012) [The review of hematologic and other biochemical parameters in lithium monotherapy patients]. Psychiatry and Behavioral Sciences, 2 (3), 109-114. Turkish. doi:10.5455/jmood.20120711044126